// App-Quantinova.ai

PO‐215 : Mobilising PBSC for autologous transplantation: comparing cyclophosphamide 1.5 g/m2 against 750 mg/m2

Researchers

Presenter

  • A Gibson

Principal Investigators

  • K Douglas

Medical Centers

  • Greater Glasgow and Clyde Health Board, Glasgow, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Cluster of Differentiation 34

  • Granulocyte colony-stimulating factor

  • Cerebrospinal fluid

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Plerixafor

  • Filgrastim

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved